Moxifloxacine Eg (Moxifloxacin)

Moxifloxacin works by binding to bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for DNA supercoiling and relaxation during replication and transcription. Inhibiting them blocks bacterial DNA synthesis, leading to rapid bacterial cell death and a broad spectrum of antibacterial activity.

The specific dose and duration of therapy are determined by the prescribing clinician based on the infection being treated, patient characteristics, and local guidelines. Moxifloxacine Eg is a prescription‑only product, and the prescriber will set the appropriate regimen.

Safety data for moxifloxacin in pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss individual risk factors with the patient and consider alternative agents when possible.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Moxifloxacin offers a broader spectrum against atypical respiratory pathogens and higher potency against Gram‑positive organisms compared with older fluoroquinolones such as ciprofloxacin. It also has a longer half‑life, allowing once‑daily dosing in many infections. However, safety considerations like tendon toxicity and QT prolongation are similar across the class, so individual patient risk must guide selection.

Moxifloxacine Eg should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in high‑heat environments such as car trunks or near radiators, and keep out of reach of children.

The medication is taken orally, usually as a tablet. It can be swallowed with or without food, although taking it with a full glass of water is recommended to aid absorption. Patients should follow the prescriber’s instructions regarding timing and whether it should be taken on an empty stomach.

Serious adverse events include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation that can precipitate ventricular arrhythmias; and severe hypersensitivity reactions such as Stevens‑Johnson syndrome, toxic epidermal necrolysis, or anaphylaxis. Prompt medical attention is required if any of these events occur.

Moxifloxacine Eg is contraindicated in patients with a known hypersensitivity to moxifloxacin or any other fluoroquinolone. It should be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, and in patients with significant QT prolongation or uncontrolled electrolyte abnormalities. Caution is also advised for those with severe renal or hepatic impairment.